Biofrontera Q4 EPS $0.48 Beats $0.20 Estimate, Sales $17.100M Beat $16.146M Estimate

Biofrontera (NASDAQ:BFRI) reported Q4 earnings of $0.48 per share, exceeding the analyst estimate of $0.20 by 146.15%, and marking a 352.63% increase from a loss of $(0.19) per share in the same period last year. The company's quarterly sales reached $17.100 million, surpassing the $16.146 million estimate by 5.91% and reflecting a 36.15% increase from $12.560 million in the prior year.